I

    ITRM (ITRM)

    Official site

    BIOTECHNOLOGY

    $0.03
    +0.00 (+0.00%)

    Last updated: Aug 31, 2026 at 5:00 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    58%(18/31)
    Avg Surprise
    -25.02%

    Upcoming Estimates

    Period ending Mar 31, 2026
    EPS Consensus$-0.10
    Range$-0.10 - $-0.10
    1 analysts
    EPS RevisionsNo revisions (7d)No revisions (30d)
    EPS Estimate Drift
    90d ago$-0.07+30.0%
    60d ago$-0.07+30.0%
    30d ago$-0.07+30.0%
    7d ago$-0.07+30.0%
    Current$-0.10
    Revenue Consensus
    $0
    Range$0 - $0
    0 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Mar 26EST
    		-$-0.10---
    Dec 25
    Reported Mar 12
    		$0.00N/A-100.00%Miss+100.0%
    Sep 25
    Reported Nov 14
    		$-0.20$-0.21+4.76%Beat+16.7%
    Jun 25
    Reported Aug 5
    		$-0.16$-0.11-45.45%Miss+46.7%
    Mar 25
    Reported May 13
    		$-0.14$-0.14+0.00%Beat+69.6%
    Dec 24
    Reported Feb 7
    		$-0.12$-0.24+50.00%Beat+87.2%
    Sep 24
    Reported Nov 14
    		$-0.24$-0.21-14.29%Miss+20.0%
    Jun 24
    Reported Aug 14
    		$-0.30$-0.45+33.33%Beat+68.4%
    Mar 24
    Reported May 13
    		$-0.46$-0.72+36.11%Beat+20.7%
    Dec 23
    Reported Mar 28
    		$-0.94$-0.93-1.08%Miss-80.8%
    Sep 23
    Reported Nov 14
    		$-0.30N/A+67.03%Beat+69.1%
    Jun 23
    Reported Aug 11
    		$-0.95$-0.79-20.25%Miss-58.3%
    Mar 23
    Reported May 12
    		$-0.58N/A+50.85%Beat-93.3%
    Dec 22
    Reported Mar 16
    		$-0.52N/A+54.78%Beat-73.3%
    Sep 22
    Reported Nov 10
    		$-0.97$-1.05+7.62%Beat-423.3%
    Jun 22
    Reported Aug 12
    		$-0.60$-1.05+42.86%Beat-200.0%
    Mar 22
    Reported May 13
    		$-0.30N/A+60.00%Beat+97.5%
    Dec 21
    Reported Mar 28
    		$-0.30$-0.60+50.00%Beat+92.6%
    Sep 21
    Reported Nov 12
    		$0.30N/A-83.33%Miss+103.3%
    Jun 21
    Reported Aug 13
    		$0.60$-0.97+161.86%Beat+105.0%
    Mar 21
    Reported May 14
    		$-12.15$-1.05-1057.14%Miss+10.0%
    Dec 20
    Reported Mar 12
    		$-4.05$-2.90-39.66%Miss+83.0%
    Sep 20
    Reported Nov 16
    		$-9.00$-7.70-16.88%Miss+72.1%
    Jun 20
    Reported Aug 6
    		$-12.00$-12.15+1.23%Beat+58.5%
    Mar 20
    Reported May 14
    		$-13.50$-20.06+32.70%Beat+37.5%
    Dec 19
    Reported Mar 12
    		$-23.85$-25.54+6.62%Beat+7.6%
    Sep 19
    Reported Nov 12
    		$-32.25$-24.71-30.51%Miss-73.4%
    Jun 19
    Reported Aug 14
    		$-28.95$-22.95-26.14%Miss+13.1%
    Mar 19
    Reported May 14
    		$-21.60$-20.20-6.93%Miss-4809.1%
    Dec 18
    Reported Mar 25
    		$-25.80$-33.71+23.46%Beat-129100.0%
    Sep 18
    Reported Nov 14
    		$-18.60$-29.51+36.97%Beat-
    Jun 18
    Reported Aug 14
    		$-33.30$-21.60-54.17%Miss-
    Mar 18
    Reported May 25
    		$-0.44N/AN/ABeat-
    Dec 17
    Reported Mar 30
    		$0.02$0.00N/ABeat-

    Key Metrics

    Valuation
    P/E Ratio-0.05EV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit MarginN/AOperating MarginN/A
    ROEN/AROIC-92.54%
    Financial Health
    Debt/Equity-4.57xInterest Coverage-10.61x
    Current Ratio2.13xQuick Ratio1.96x
    Trading Statistics
    BetaN/AAvg VolumeN/A
    52-Week HighN/A52-Week LowN/A

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$0.03
    SMA 20$0.03
    SMA 50$0.03
    SMA 200$0.17
    EMA 10$0.03
    EMA 20$0.03
    EMA 50$0.03
    EMA 200$0.21

    MACD

    Line: N/ASignal: -0.00Hist: N/A

    ADX

    ADX: 61.3+DI: 10.4-DI: 43.2

    Aroon & PSAR

    Aroon Up100.0
    Aroon Down100.0
    PSAR$0.03

    Bollinger Bands

    Upper Band$0.03
    Lower Band$0.03
    %B Position0%(Lower)
    Band Width0.50

    RSI (14-Day)

    Oversold
    25.8

    Momentum Oscillators

    Stoch %KN/A
    Stoch %DN/A
    Williams %RN/A
    ROC (10d)N/A
    MomentumN/A
    CCI (20d)N/A
    MFI (14d)N/A

    Volatility Measures

    ATR (14d)N/A(0.1%)
    StdDev (20d)N/A
    Hist VolN/A

    Volume Flow

    VWAP$0.03
    OBV588.1M
    AD Line-399.5M
    CMF (20d)N/A

    Volume Metrics

    Avg Vol (20d)N/A
    Vol RatioN/A
    VWMA (20d)N/A

    Pivot Points

    R3$0.03
    R2$0.03
    R1$0.03
    Pivot Point$0.03
    S1$0.03
    S2$0.03
    S3$0.03

    Advanced Oscillators

    TSI-49.32
    Ultimate OscN/A
    KSTN/A

    Financial Data

    QuarterSep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022
    Total Revenue$390,000$0$0$0$0$0$0$2.62M$0$0$0$0
    Cost of Revenue$20,000$696,000$342,000$238,999$8,000$8,000$7,000$440,000$436,000$438,000$436,000$439,000
    Gross Profit$370,000$-696,000$-342,000$-239,000$0$-8,000$-7,000$-440,000$-436,000$-438,000$-436,000$-439,000
    Operating Expenses$7.75M$4.83M$3.37M$3.67M$4.89M$3.98M$6.16M$10.99M$16.68M$10.82M$8.53M$7.93M
    R&D$1.26M$649,000$591,000$1.30M$3.11M$2.08M$3.97M$9.30M$14.85M$8.96M$6.43M$5.84M
    SG&A$6.49M$4.18M$2.78M$2.12M$1.78M$1.90M$2.19M$1.69M$1.83M$1.86M$2.10M$2.09M
    Operating Income$-7,382,000$-5,529,000$-3,710,000$-3,670,000$-4,887,000$-3,976,000$-6,163,000$-11,431,000$-16,685,000$-10,822,000$-8,530,000$-7,926,000
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$441,000$449,000$534,000$874,000$590,000$571,000$487,000$405,000$300,000$324,000$399,000$80,000
    Income Before Tax$-8,847,000$-6,450,000$-4,831,000$-6,557,000$-5,958,000$-4,966,000$-7,053,000$-12,220,000$-3,716,000$-12,056,000$-9,766,000$-4,989,000
    Income Tax Expense$132,000$59,000$60,000$25,000$136,000$31,000$48,000$142,000$161,000$187,000$123,000$101,000
    Net Income$-8,979,000$-6,509,000$-4,891,000$-6,582,000$-6,094,000$-4,997,000$-7,101,000$-12,362,000$-3,877,000$-12,243,000$-9,889,000$-5,090,000
    EBITDA$-8,051,000$-5,650,000$-3,948,000$-5,422,000$-5,360,000$-4,387,000$-6,559,000$-11,375,000$-2,980,000$-11,294,000$-8,931,000$-4,630,000
    EBIT$-8,406,000$-6,001,000$-4,297,000$-5,683,000$-5,368,000$-4,395,000$-6,566,000$-11,815,000$-3,416,000$-11,732,000$-9,367,000$-5,069,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about ITRM

    News

    Iterum Therapeutics plc Revenue Breakdown – OTC:ITRMF

    This page provides financial information for Iterum Therapeutics plc (OTC:ITRMF) on TradingView. It offers an overview of the company's financials, including statements, statistics, dividends, earnings, and segments. Users can access data on top segments and regional performance by source and country.

    TradingView•7/25/26•
    Neutral

    Price to earnings forward of Iterum Therapeutics plc – OTC:ITRMF

    This article provides financial information for Iterum Therapeutics plc, specifically its price to earnings forward metric. The content, presented through TradingView, shows current market data and notes that the market for ITRMF is currently closed with no trades. Key financial and market data are sourced from ICE Data Services and FactSet.

    TradingView•7/2/26•
    Neutral

    Iterum Therapeutics plc Actuals & Estimates (OTC:ITRMF)

    This article provides an overview of Iterum Therapeutics plc (OTC:ITRMF) stock, including its current price, historical performance, and financial data. It highlights that the stock has seen a significant increase in the past 24 hours and past week but a decrease over the month and year. The company's market capitalization, recent earnings, and revenue figures are also detailed.

    TradingView•6/25/26•
    Neutral

    ITRMF SEC Filings - Iterum Therapeutics Plc 10-K, 10-Q, 8-K Forms

    This page on StockTitan provides access to SEC filings for Iterum Therapeutics Plc (ITRMF), including 10-K, 10-Q, and 8-K forms, alongside Form 4 insider trading disclosures. Each filing is accompanied by an AI-generated summary, sentiment analysis, impact scores, and end-of-day stock performance data. The most recent filing, from June 23, 2026, details the company's Form 25 to remove its Ordinary Shares from Nasdaq.

    Stock Titan•6/23/26•
    Neutral

    ITRMF Stock Price, News & Analysis

    Iterum Therapeutics Plc (ITRMF) is a publicly traded biotechnology company with a market capitalization of $2.2M. The stock has seen a 5.4% decline over the past year, and its last traded price was $0.0400. The company reported a net income of -$24.8M and diluted EPS of $-1.26 on a trailing twelve-month basis.

    Stock Titan•6/23/26•
    Neutral

    Frequently Asked Questions About ITRM

    Does ITRM pay dividends?
    ITRM (ITRM) does not currently pay a regular dividend.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In